SLC45A3
Summary:
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
solute carrier family 45 member 3 | MIM:605097 | Ensembl:ENSG00000158715 | HGNC:HGNC:8642 | PA32981 | 1q32.1 |
GO terms in SLC45A3
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
CC | TAS | GO:0005886 | plasma membrane |
CC | IEA | GO:0016021 | integral component of membrane |
BP | TAS | GO:0008645 | hexose transmembrane transport |
BP | ISS | GO:0010907 | positive regulation of glucose metabolic process |
BP | ISS | GO:0015770 | sucrose transport |
BP | ISS | GO:0045723 | positive regulation of fatty acid biosynthetic process |
BP | ISS | GO:0048713 | regulation of oligodendrocyte differentiation |
MF | ISS | GO:0008506 | sucrose:proton symporter activity |
MF | TAS | GO:0051119 | sugar transmembrane transporter activity |
Gene expression in normal tissue: SLC45A3
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in SLC45A3
Database | Pathway ID | Pathway Des. |
---|---|---|
kegg | hsa05202 | Transcriptional misregulation in cancer - Homo sapiens (human) |
kegg | hsa05206 | MicroRNAs in cancer - Homo sapiens (human) |
reactome | R-HSA-189200 | Cellular hexose transport |
reactome | R-HSA-382551 | Transport of small molecules |
reactome | R-HSA-425407 | SLC-mediated transmembrane transport |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD138 | PX 12 | 3 |
iGMDRD330 | BRD4132 | 1 |
iGMDRD599 | Salermide | 6 |
iGMDRD5 | Tyrphostin AG 1478 | 3 |
iGMDRD144 | NSC95397 | 3 |
iGMDRD188 | Piperlongumine | 6 |
iGMDRD341 | Triacsin c | 3 |
iGMDRD85 | Ursolic acid | 3 |
iGMDRD329 | Merck60 | 3 |
iGMDRD398 | Sepantronium | 3 |
iGMDRD61 | Kinetin riboside | 3 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in SLC45A3